Development of a Quantitative Systems Pharmacology (QSP) Platform to Support Translational Research and Clinical Development in Immuno-Oncology

被引：0

作者：

Schmidt, Brian J. ^{[1
]}

Bartlett, Derek W. ^{[2
]}

Agrawal, Shruti ^{[1
]}

Reed, Michael ^{[2
]}

Jure-Kunkel, Maria ^{[1
]}

Gutierrez, Andres A. ^{[1
]}

Clynes, Raphael A. ^{[1
]}

Fischer, Bruce S. ^{[1
]}

Surywanshi, Satyendra ^{[1
]}

Kadambi, Ananth ^{[2
]}

Friedrich, Christina ^{[2
]}

Kudrycki, Katherine ^{[2
]}

Roy, Amit ^{[1
]}

Leil, Tarek A. ^{[1
]}

机构：

[1] Bristol Myers Squibb Co, Princeton, NJ USA

[2] Rosa & Co, San Carlos, CA USA

来源：

JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2015年 / 42卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

M-27

引用

页码：S22 / S23

页数：2

共 50 条

[41] Immuno-Oncology: The Third Paradigm in Early Drug Development
Juan Martin-Liberal
Cinta Hierro
Maria Ochoa de Olza
Jordi Rodon
Targeted Oncology, 2017, 12 : 125 - 138
[42] Cell-based assay to support development and characterization of new drugs in immuno-oncology
Haque, Mohammad
Salam, Safnas Abdul
McGinley, Shawn
Ma, Haiching
Wu, Jianghong
CANCER RESEARCH, 2023, 83 (07)
[43] New patient-derived head and neck cancer xenograft (PDX) panel for drug development, immuno-oncology and translational research
Brzezicha, Bernadette
Conrad, Theresia
Stecklum, Maria
Becker, Michael
Klinghammer, Konrad
Hoffmann, Jens
CLINICAL CANCER RESEARCH, 2023, 29 (18)
[44] Enhancing Value of Clinical Pharmacodynamics in Oncology Drug Development: An Alliance Between Quantitative Pharmacology and Translational Science
Venkatakrishnan, K.
Ecsedy, J. A.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (01) : 99 - 113
[45] Dynamical systems analysis as an additional tool to inform treatment outcomes: The case study of a quantitative systems pharmacology model of immuno-oncology
Balti, Aymen
Zugaj, Didier
Fenneteau, Frederique
Tremblay, Pierre-Olivier
Nekka, Fahima
CHAOS, 2021, 31 (02)
[46] Pharmacometric Applications and Challenges in the Development of Therapeutic Antibodies in Immuno-Oncology
Diao L.
Meibohm B.
Current Pharmacology Reports, 2018, 4 (4) : 285 - 291
[47] Application of quantitative pharmacology analysis to support early clinical development of oncology drugs: dose selection
Zhang, Ningyuan
Li, Yu
Cui, Wenbin
Yu, Xiangqing
Huang, Ying
XENOBIOTICA, 2024, 54 (07) : 420 - 423
[48] Development of a Quantitative Systems Pharmacology (QSP) Toolbox and Virtual Population (VPop) for Affinity-Drug Conjugate (ADC) Research
Cheng, Yougan
Vezina, Heather E.
Gupta, Manish
Pan, Chin
Leil, Tarek A.
Schmidt, Brian J.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S47 - S47
[49] Applications of Quantitative Systems Pharmacology (QSP) in Drug Development for NAFLD and NASH and Its Regulatory Application
Siler, Scott Q.
PHARMACEUTICAL RESEARCH, 2022, 39 (08) : 1789 - 1802
[50] Patient-derived xenograft (PDX) and corresponding cell line models from glioblastoma for drug development, immuno-oncology and translational research
Alcaniz, Joshua
Winkler, Lars
Stecklum, Maria
Wieland, Hagen
Siegert, Antje
Becker, Michael
Brzezicha, Bernadette
Walther, Wolfgang
Hoffmann, Jens
CANCER RESEARCH, 2023, 83 (07)

← 1 2 3 4 5 →